Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-089804
Filing Date
2024-08-14
Accepted
2024-08-14 19:48:54
Documents
2
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2421559-9_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2421559-9_3seq1.xml 3 3305
2 EXHIBIT 24 tm2421559d9_ex-24.htm EX-24 8034
  Complete submission text file 0001104659-24-089804.txt   13098
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Issuer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-984-9197
Bios 2024 Co-Invest, LP (Reporting) CIK: 0002028708 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42139 | Film No.: 241210204